Elicio Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Elicio Therapeutics, Inc. (ELTX) reported Increase (Decrease) in Other Noncurrent Assets of $55.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-13
- Elicio Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$170.00K.
- Elicio Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $225.00K.
- Elicio Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $0.00.
- Elicio Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $170.00K.
- Elicio Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $170.00K.
- Elicio Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$2.23M.
- Elicio Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00.
- Elicio Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$114.00K, a 207.55% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $55.00K 10-Q · filed 2026-08-13 | $55.00K derived: sum of 3 quarters · filed 2026-08-13 | $225.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $225.00K 10-Q · filed 2026-05-11 | $225.00K derived: sum of 2 quarters · filed 2026-05-11 | $395.00K derived: sum of 3 quarters · filed 2026-05-11 | $395.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $170.00K derived: sum of 2 quarters · filed 2026-03-12 | $170.00K derived: sum of 3 quarters · filed 2026-08-13 | $170.00K 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $170.00K derived: sum of 2 quarters · filed 2026-08-13 | $170.00K 10-Q · filed 2025-11-13 | $170.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | -$1.03M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | -$1.03M derived: sum of 3 quarters · filed 2026-05-11 | -$2.07M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.03M derived: sum of 2 quarters · filed 2026-03-12 | -$2.07M derived: sum of 3 quarters · filed 2026-03-12 | -$2.23M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.07M derived: sum of 2 quarters · filed 2025-11-13 | -$2.23M 10-Q · filed 2025-11-13 | -$2.23M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.20M 10-Q · filed 2025-08-07 | -$1.20M derived: sum of 3 quarters · filed 2025-08-07 | -$1.21M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$160.00K 10-Q · filed 2025-05-13 | -$160.00K derived: sum of 2 quarters · filed 2025-05-13 | -$168.00K derived: sum of 3 quarters · filed 2025-05-13 | $37.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$8.00K derived: sum of 2 quarters · filed 2025-03-31 | $197.00K derived: sum of 3 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $197.00K derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $8.00K 10-Q · filed 2024-08-13 | $8.00K derived: sum of 3 quarters · filed 2024-08-13 | $8.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$197.00K 10-Q · filed 2024-05-15 | $851.00K 10-Q · filed 2023-05-10 | -$197.00K derived: sum of 2 quarters · filed 2024-05-15 | -$197.00K derived: sum of 3 quarters · filed 2024-05-15 | -$283.00K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | -$86.00K derived: sum of 3 quarters · filed 2024-03-29 | -$114.00K 10-K · filed 2024-03-29 | -$45.00K 10-K · filed 2023-03-17 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$86.00K derived: sum of 2 quarters · filed 2023-11-13 | -$114.00K 10-Q · filed 2023-11-13 | -$31.00K 10-Q · filed 2022-11-14 | -$41.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$114.00K 10-Q · filed 2023-08-14 | -$19.00K 10-Q · filed 2022-08-15 | -$41.00K derived: sum of 3 quarters · filed 2023-08-14 | -$46.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$28.00K 10-Q · filed 2023-05-10 | $45.00K derived: sum of 2 quarters · filed 2023-05-10 | $40.00K derived: sum of 3 quarters · filed 2023-05-10 | $40.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $68.00K derived: sum of 2 quarters · filed 2023-03-17 | $68.00K derived: sum of 3 quarters · filed 2023-03-17 | $106.00K 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$5.00K derived: sum of 2 quarters · filed 2022-11-14 | $33.00K 10-Q · filed 2022-11-14 | $33.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $38.00K 10-Q · filed 2022-08-15 | $38.00K derived: sum of 3 quarters · filed 2022-08-15 | $38.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $38.00K 10-Q · filed 2022-05-16 | $38.00K derived: sum of 2 quarters · filed 2022-05-16 | $38.00K derived: sum of 3 quarters · filed 2022-05-16 | $38.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |